Theme: Glycobiology: Simple construction of sweet glycoprobes

Glycobiology 2017

Renowned Speakers

Glycobiology 2017

Welcome Message from Dr. Neil P. J. Price

speaker

Neil P. J. Price
USDA, Agricultural Research Service
NCAUR, Peoria, IL, USA

Dear Colleagues,

On behalf of the organizing committee and the Conference Series LLC, it is my pleasure to welcome you to Glycobiology-2017, to be held during June 26-28, 2017 in London, England. This is the 3rd annual Glycobiology World Congress, following successful previous conferences held in Philadelphia, 2015 and Atlanta, 2016. We extend this welcome to all of the participants from across the globe to take part in this premier event in the beautiful city of London.

The field of glycobiology has moved rapidly since our first Glycobiology conference in 2015. Antibiotic and vaccine development, and renewable bio-energy are major drivers of new research and applications. Technical advances have occurred, especially in mass spectrometry, glycomics, NMR, and labeling and imaging technologies. Biomedical and basic fundamental research into glycolytic enzymes, metabolism, prebiotic oligosaccharides, and plant and microbial cell walls have highlighted the importance of glycobiology to the commercially important businesses of biotechnology and medicine.

Glycobiology-2017, hosted by Conference Series LLC Meetings, is a three day event consisting of a scientific program, comprehensive talks, special sessions, and oral & poster presentations of peer-reviewed contributed papers. We provide a platform where you can exchange your knowledge and experiences with the developing trends in the related fields of glycobiology and carbohydrates. We anticipate interesting new ideas being opened up via the research talks and presentations, and I am looking forward to meeting with you at London, UK this June.

With my regards,

Dr. Neil P. J. Price
USDA, Agricultural Research Service
NCAUR, Peoria, IL, USA

 

 









Welcome Message

Welcome Message from Dr. Neil P. J. Price

speaker

Neil P. J. Price
USDA, Agricultural Research Service
NCAUR, Peoria, IL, USA

Dear Colleagues,

On behalf of the organizing committee and the Conference Series LLC, it is my pleasure to welcome you to Glycobiology-2017, to be held during June 26-28, 2017 in London, England. This is the 3rd annual Glycobiology World Congress, following successful previous conferences held in Philadelphia, 2015 and Atlanta, 2016. We extend this welcome to all of the participants from across the globe to take part in this premier event in the beautiful city of London.

The field of glycobiology has moved rapidly since our first Glycobiology conference in 2015. Antibiotic and vaccine development, and renewable bio-energy are major drivers of new research and applications. Technical advances have occurred, especially in mass spectrometry, glycomics, NMR, and labeling and imaging technologies. Biomedical and basic fundamental research into glycolytic enzymes, metabolism, prebiotic oligosaccharides, and plant and microbial cell walls have highlighted the importance of glycobiology to the commercially important businesses of biotechnology and medicine.

Glycobiology-2017, hosted by Conference Series LLC Meetings, is a three day event consisting of a scientific program, comprehensive talks, special sessions, and oral & poster presentations of peer-reviewed contributed papers. We provide a platform where you can exchange your knowledge and experiences with the developing trends in the related fields of glycobiology and carbohydrates. We anticipate interesting new ideas being opened up via the research talks and presentations, and I am looking forward to meeting with you at London, UK this June.

With my regards,

Dr. Neil P. J. Price
USDA, Agricultural Research Service
NCAUR, Peoria, IL, USA

 





Sessions/Tracks

Conference Series LLC invites all the participants across the globe to attend the 3rd Glycobiology World Congress (Glycobiology -2017) during June 26-282017 at London, UK.

The conference was marked with the attendance of Editorial Board Members, Scientists, young and brilliant researchers, business delegates and talented student communities representing more than 25 countries, who made this conference fruitful and productive. Glycobiology-2017 mainly concentrates on Role of glycans and there Infectious Diseases, amalgamating the branches of Biochemistry where the specialization deals with the diagnosis and treatment of Diseases and its related fields. Glycobiology -2017  hosted  by  Conference Series LLC meetings which is  a three day event consisting of a scientific program, comprehensive talks, special sessions, oral & poster presentations of peer-reviewed contributed papers and exciting and innovative research products which can be exhibited for the further development of Glycobiology. We provide a platform where you can exchange your knowledge and experiences with the developing trends in the related fields of Glycobiology. Glycobiology -2017 will schedule and coordinate all meetings with our Editorial Board Members and other experts in the Glycobiology field across the world. The scientific program paves a way to gather visionaries through the research talks and presentations and put forward many thought provoking strategies on Glycobiology-2017.

Glycobiology conference -2017 is designed to meet all renowned and eminent speakers from all around the globe with delegates, exhibitors, industry experts and work shop symposiums.

For more details: http://glycobiology.conferenceseries.com/

Scientific Sessions:

Track: 1 Glycans in Drug Design

Glycans are components of many bio-therapeutic agents, ranging from natural products to molecules based on rational design to recombinant glycoproteins. The glycan components of these agents can be important determinants of their biological activity and therapeutic efficacy. Biochemistry and Glycobiology involves a multidisciplinary study of carbohydrate-binding proteins (lectins), glycolipids  and some other plant proteins that are capable of interacting with endogenous or foreign (macro) molecules. The emphasis of the research is on protein-carbohydrate interaction and their involvement in signalling processes in plants or in plant protection. Based on the generated fundamental knowledge novel strategies are being developed to protect crop plants against pests and diseases.

Relevant Conferences: Glycobiology Conferences Biochemistry Conferences

7th International Conference on Bioinformatics, October 24-26, 2016 Rome, Italy; International Conference on Structural Biology, August 22-23, 2016 New Orleans, USA; International Conference on Glycomics, December 01-02, 2016 Atlanta, Georgia, USA; International Conference on Nucleic Acids, August 04-05, 2016 New Orleans, Louisiana, USA; 2nd International Conference on Transcriptomics, September 12-14, 2016 Philadelphia, Pennsylvania, USA; International Conference on Obesity & Chronic Diseases, July 25-27, 2016 Las Vegas USA; International Conference on New Therapeutics for Diabetes and Obesity, April 17-20, 2016 La Jolla, USA; Conference on Plasma Spectrochemistry, January 10-16, 2016 Tucson, USA; Euro Fed Lipid Congress, September 18-21, 2016 Gent, Belgium; Conference on Obesity and Adipose Tissue Biology, February 15-19, 2016 Banff, Canada; Society for Glycobiology, November 19-22, 2016 New Orleans, Louisiana, USA; American Society for Biochemistry and Molecular Biology (ASBMB), April 02-06, 2016 San Diego, USA; Federation of American Societies for Experimental Biology (FASEB), June 12-17, 2016 Florida, USA

Track: 2 Glyco-proteomics

Glycobiology along with the field of proteomics, particularly the application of mass spectrometry analysis to protein samples, is well-established and growing rapidly. Proteomics studies along with glycans generate large volumes of raw experimental data and inferred biological results. To facilitate the dissemination of these data, centralized data repositories have been developed that make the data and results accessible to proteomics researchers and biologists alike. Experimental analysis of proteomics data repositories focuses exclusively on freely-available, centralized data resources that disseminate or store experimental mass spectrometry data and results.

Relevant Conferences: Glycobiology Conferences Biochemistry Conferences

7th International Conference on Bioinformatics, October 24-26, 2016 Rome, Italy; International Conference on Structural Biology, August 22-23, 2016 New Orleans, USA; International Conference on Glycomics, December 01-02, 2016 Atlanta, Georgia, USA; International Conference on Nucleic Acids, August 04-05, 2016 New Orleans, Louisiana, USA; 2nd International Conference on Transcriptomics, September 12-14, 2016 Philadelphia, Pennsylvania, USA; International Conference on Obesity & Chronic Diseases, July 25-27, 2016 Las Vegas USA; International Conference on New Therapeutics for Diabetes and Obesity, April 17-20, 2016 La Jolla, USA; Conference on Plasma Spectrochemistry, January 10-16, 2016 Tucson, USA; Euro Fed Lipid Congress, September 18-21, 2016 Gent, Belgium; Conference on Obesity and Adipose Tissue Biology, February 15-19, 2016 Banff, Canada; Society for Glycobiology, November 19-22, 2016 New Orleans, Louisiana, USA; American Society for Biochemistry and Molecular Biology (ASBMB), April 02-06, 2016 San Diego, USA; Federation of American Societies for Experimental Biology (FASEB), June 12-17, 2016 Florida, USA

Track: 3 Glyco-Bioinformatics

Glycobiology and Glycochemistry are the two main intertwined areas of Glycosciences, dealing with various aspects of glycans, including carbohydrate structure, biochemistry, biological functions and applications. This is necessary in order to sustain and advance the identification of key glycobiological aspects and the application of glycans and glycoengineering strategies in the design of novel therapies to improve human health. The glycans (carbohydrates) form a diverse group of biomolecules which play active parts in most physiological processes. The field of structural glycobiology concerns the structures of the glycans themselves, the proteins which interact with them and the nature of the interactions between the two. Drug targeting is important for our understanding of human health and disease, and for development of new therapeutic strategies.

Relevant Conferences: Glycobiology Conferences Biochemistry Conferences

7th International Conference on Bioinformatics, October 24-26, 2016 Rome, Italy; International Conference on Structural Biology, August 22-23, 2016 New Orleans, USA; International Conference on Glycomics, December 01-02, 2016 Atlanta, Georgia, USA; International Conference on Nucleic Acids, August 04-05, 2016 New Orleans, Louisiana, USA; 2nd International Conference on Transcriptomics, September 12-14, 2016 Philadelphia, Pennsylvania, USA; International Conference on Obesity & Chronic Diseases, July 25-27, 2016 Las Vegas USA; International Conference on New Therapeutics for Diabetes and Obesity, April 17-20, 2016 La Jolla, USA; Conference on Plasma Spectrochemistry, January 10-16, 2016 Tucson, USA; Euro Fed Lipid Congress, September 18-21, 2016 Gent, Belgium; Conference on Obesity and Adipose Tissue Biology, February 15-19, 2016 Banff, Canada; Society for Glycobiology, November 19-22, 2016 New Orleans, Louisiana, USA; American Society for Biochemistry and Molecular Biology (ASBMB), April 02-06, 2016 San Diego, USA; Federation of American Societies for Experimental Biology (FASEB), June 12-17, 2016 Florida, USA

Track: 4 Glyco Immunology

Glycomics the scientific attempt to characterize and study carbohydrates, is a rapidly emerging branch of science, for which informatics is just beginning. Glycomics requires sophisticated algorithmic approaches. Several algorithms and models have been developed for glycobiology research in the past several years. The development and use of informatics tools and databases for glycobiology and glycomics research has increased considerably in recent years. However, the general development in this field can still be considered as being in its infancy when compared to the genomics and proteomics areas. In terms of bioinformatics in glycobiology, there are several paths of research that are currently in progress. The development of algorithms and software tools for interpretation of glycans to reliably support the characterization of glycan structures for high-throughput applications is the most immediate demand of the glycomics community.

Relevant Conferences: Glycobiology Conferences Biochemistry Conferences

7th International Conference on Bioinformatics, October 24-26, 2016 Rome, Italy; International Conference on Structural Biology, August 22-23, 2016 New Orleans, USA; International Conference on Glycomics, December 01-02, 2016 Atlanta, Georgia, USA; International Conference on Nucleic Acids, August 04-05, 2016 New Orleans, Louisiana, USA; 2nd International Conference on Transcriptomics, September 12-14, 2016 Philadelphia, Pennsylvania, USA; International Conference on Obesity & Chronic Diseases, July 25-27, 2016 Las Vegas USA; International Conference on New Therapeutics for Diabetes and Obesity, April 17-20, 2016 La Jolla, USA; Conference on Plasma Spectrochemistry, January 10-16, 2016 Tucson, USA; Euro Fed Lipid Congress, September 18-21, 2016 Gent, Belgium; Conference on Obesity and Adipose Tissue Biology, February 15-19, 2016 Banff, Canada; Society for Glycobiology, November 19-22, 2016 New Orleans, Louisiana, USA; American Society for Biochemistry and Molecular Biology (ASBMB), April 02-06, 2016 San Diego, USA; Federation of American Societies for Experimental Biology (FASEB), June 12-17, 2016 Florida, USA

Track: 5 Glyco-Biomarkers

Glycans can mediate a wide variety of biological roles by virtue of their mass, shape, charge, or other physical properties. However, many of their more specific biological roles are mediated via recognition by GBPs. Nature appears to have taken full advantage of the vast diversity of glycans expressed in organisms by evolving protein modules to recognize discrete glycans that mediate specific physiological or pathological processes. Excluding glycan-specific antibodies, GBPs broadly into two major groups such as lectins and glycosaminoglycan-binding proteins. Most lectins are members of families with defined “carbohydrate-recognition domains” (CRDs) that apparently evolved from shared ancestral genes, often retaining specific features of primary amino acid sequence or three-dimensional structure. Thus, new family members can be identified by searching protein sequence or structural databases. The natural ligands for most lectins are typically complex glycoconjugates that carry clustered arrays of the cognate carbohydrate or unique glycan structures, thus cooperating with clustered lectin-binding sites to generate high-avidity binding, which is further enhanced by mass transport effects (high local concentrations of ligands).

Relevant Conferences: Glycobiology Conferences Biochemistry Conferences

7th International Conference on Bioinformatics, October 24-26, 2016 Rome, Italy; International Conference on Structural Biology, August 22-23, 2016 New Orleans, USA; International Conference on Glycomics, December 01-02, 2016 Atlanta, Georgia, USA; International Conference on Nucleic Acids, August 04-05, 2016 New Orleans, Louisiana, USA; 2nd International Conference on Transcriptomics, September 12-14, 2016 Philadelphia, Pennsylvania, USA; International Conference on Obesity & Chronic Diseases, July 25-27, 2016 Las Vegas USA; International Conference on New Therapeutics for Diabetes and Obesity, April 17-20, 2016 La Jolla, USA; Conference on Plasma Spectrochemistry, January 10-16, 2016 Tucson, USA; Euro Fed Lipid Congress, September 18-21, 2016 Gent, Belgium; Conference on Obesity and Adipose Tissue Biology, February 15-19, 2016 Banff, Canada; Society for Glycobiology, November 19-22, 2016 New Orleans, Louisiana, USA; American Society for Biochemistry and Molecular Biology (ASBMB), April 02-06, 2016 San Diego, USA; Federation of American Societies for Experimental Biology (FASEB), June 12-17, 2016 Florida, USA

Track: 6 Glycoprotein Technologies

Glycans quickly became overshadowed as DNA- and protein-focused treatments became readily accessible. The recent development of new tools and techniques to study and produce structurally defined carbohydrates has spurred renewed interest in the therapeutic applications of glycans. Glycan Analysis review focuses on advances within the past decade that are bringing glycan-based treatments back to the forefront of medicine and the technologies that are driving these efforts. These include the use of glycans themselves as therapeutic molecules as well as engineering protein and cell surface glycans to suit clinical applications to that of databases providing glycoenzyme data. Glycoconjugates offer a rich and promising frontier for developments in the academic, biopharmaceutical, and medical fields.

Relevant Conferences: Glycobiology Conferences Biochemistry Conferences

7th International Conference on Bioinformatics, October 24-26, 2016 Rome, Italy; International Conference on Structural Biology, August 22-23, 2016 New Orleans, USA; International Conference on Glycomics, December 01-02, 2016 Atlanta, Georgia, USA; International Conference on Nucleic Acids, August 04-05, 2016 New Orleans, Louisiana, USA; 2nd International Conference on Transcriptomics, September 12-14, 2016 Philadelphia, Pennsylvania, USA; International Conference on Obesity & Chronic Diseases, July 25-27, 2016 Las Vegas USA; International Conference on New Therapeutics for Diabetes and Obesity, April 17-20, 2016 La Jolla, USA; Conference on Plasma Spectrochemistry, January 10-16, 2016 Tucson, USA; Euro Fed Lipid Congress, September 18-21, 2016 Gent, Belgium; Conference on Obesity and Adipose Tissue Biology, February 15-19, 2016 Banff, Canada; Society for Glycobiology, November 19-22, 2016 New Orleans, Louisiana, USA; American Society for Biochemistry and Molecular Biology (ASBMB), April 02-06, 2016 San Diego, USA; Federation of American Societies for Experimental Biology (FASEB), June 12-17, 2016 Florida, USA

Track: 7 Genomics & Metabolomics

Genomics is a discipline in genetics that applies recombinant DNA, DNA sequencing methods and bioinformatics to sequence, assemble and analyze the function and structure of glycans along with the genomes. Metabolomics is a relatively young branch of omics science concerned with the systematic study of the chemical products or metabolites that cells and organisms generate. Indeed, most human metabolomic studies published today, even those exploiting the latest and most sensitive LC-MS/MS technologies, typically succeed in identifying or characterizing fewer than 100 compounds. This corresponds to less than 1% of the known human metabolome. In an effort to help improve this situation, we (and others) have started to undertake the systematic characterization of various human biofluid metabolomes. This includes the human cerebrospinal fluid metabolome the human saliva metabolome and the human serum metabolome. 

Relevant Conferences: Glycobiology Conferences Biochemistry Conferences

7th International Conference on Bioinformatics, October 24-26, 2016 Rome, Italy; International Conference on Structural Biology, August 22-23, 2016 New Orleans, USA; International Conference on Glycomics, December 01-02, 2016 Atlanta, Georgia, USA; International Conference on Nucleic Acids, August 04-05, 2016 New Orleans, Louisiana, USA; 2nd International Conference on Transcriptomics, September 12-14, 2016 Philadelphia, Pennsylvania, USA; International Conference on Obesity & Chronic Diseases, July 25-27, 2016 Las Vegas USA; International Conference on New Therapeutics for Diabetes and Obesity, April 17-20, 2016 La Jolla, USA; Conference on Plasma Spectrochemistry, January 10-16, 2016 Tucson, USA; Euro Fed Lipid Congress, September 18-21, 2016 Gent, Belgium; Conference on Obesity and Adipose Tissue Biology, February 15-19, 2016 Banff, Canada; Society for Glycobiology, November 19-22, 2016 New Orleans, Louisiana, USA; American Society for Biochemistry and Molecular Biology (ASBMB), April 02-06, 2016 San Diego, USA; Federation of American Societies for Experimental Biology (FASEB), June 12-17, 2016 Florida, USA

Track: 8 Glycobiology and Biotechnology

As with other major classes of macromolecules, the biological roles of glycans span the spectrum from those that appear to be relatively subtle, to those that are crucial for the development, growth, functioning, or survival of the organism that synthesizes them. The biological roles of glycans can be divided into two broad categories: (1) the structural and modulatory properties of glycans and (2) the specific recognition of glycans by other molecules most commonly, glycan-binding proteins (GBPs). The biological consequences of altering glycosylation in various systems seem to be highly variable and unpredictable. A given glycan can have different roles in different tissues or at different times in development (organism-intrinsic functions) or in different environmental contexts (organism-extrinsic functions). Approaches taken to understand the biological roles of glycans include the prevention of initial glycosylation, prevention of glycan chain elongation, alteration of glycan processing, enzymatic or chemical glycosylation of completed chains, genetic elimination of glycosylation sites, and the study of naturally occurring genetic variants and mutants in glycosylation. Glycosylation mainly refers in particular to the enzymatic process that attaches glycans to proteins, lipids, or other organic molecules. This enzymatic process produces one of the fundamental biopolymers found in cells (along with DNA, RNA, and proteins).

Relevant Conferences: Glycobiology Conferences Biochemistry Conferences

7th International Conference on Bioinformatics, October 24-26, 2016 Rome, Italy; International Conference on Structural Biology, August 22-23, 2016 New Orleans, USA; International Conference on Glycomics, December 01-02, 2016 Atlanta, Georgia, USA; International Conference on Nucleic Acids, August 04-05, 2016 New Orleans, Louisiana, USA; 2nd International Conference on Transcriptomics, September 12-14, 2016 Philadelphia, Pennsylvania, USA; International Conference on Obesity & Chronic Diseases, July 25-27, 2016 Las Vegas USA; International Conference on New Therapeutics for Diabetes and Obesity, April 17-20, 2016 La Jolla, USA; Conference on Plasma Spectrochemistry, January 10-16, 2016 Tucson, USA; Euro Fed Lipid Congress, September 18-21, 2016 Gent, Belgium; Conference on Obesity and Adipose Tissue Biology, February 15-19, 2016 Banff, Canada; Society for Glycobiology, November 19-22, 2016 New Orleans, Louisiana, USA; American Society for Biochemistry and Molecular Biology (ASBMB), April 02-06, 2016 San Diego, USA; Federation of American Societies for Experimental Biology (FASEB), June 12-17, 2016 Florida, USA

Track: 9 Glycans in Diseases and Therapeutics

Glycans are saccharides that can be attached to a wide variety of biological molecules through an enzymatic process called glycosylation to augment their function. One of the four fundamental building blocks of life, proteins, carbohydrates (glycans), lipids and nucleic acids, glycans have received the least attention from researchers. Glycans are the predominant molecule on the cell surface and serve as the first point of contact between a cell and other cells, the extracellular matrix and pathogens. The heightened evolutionary pressure of being at the front lines of cellular collaboration and conflict most likely led to the diversification of glycans. Glyco-epitope diversity enhances the role of glycans in the group of debilitating and life-shortening disorders known as congenital muscular dystrophy, or CMD. Glycosylation is a critical function of the biosynthetic-secretory pathway in the endoplasmic reticulum (ER) and Golgi apparatus. Glycosylation increases the diversity of the proteome to a level unmatched by any other post-translational modification. Glycosidases catalyze the hydrolysis of glycosidic bonds to remove sugars from proteins.

Relevant Conferences: Glycobiology Conferences Biochemistry Conferences

7th International Conference on Bioinformatics, October 24-26, 2016 Rome, Italy; International Conference on Structural Biology, August 22-23, 2016 New Orleans, USA; International Conference on Glycomics, December 01-02, 2016 Atlanta, Georgia, USA; International Conference on Nucleic Acids, August 04-05, 2016 New Orleans, Louisiana, USA; 2nd International Conference on Transcriptomics, September 12-14, 2016 Philadelphia, Pennsylvania, USA; International Conference on Obesity & Chronic Diseases, July 25-27, 2016 Las Vegas USA; International Conference on New Therapeutics for Diabetes and Obesity, April 17-20, 2016 La Jolla, USA; Conference on Plasma Spectrochemistry, January 10-16, 2016 Tucson, USA; Euro Fed Lipid Congress, September 18-21, 2016 Gent, Belgium; Conference on Obesity and Adipose Tissue Biology, February 15-19, 2016 Banff, Canada; Society for Glycobiology, November 19-22, 2016 New Orleans, Louisiana, USA; American Society for Biochemistry and Molecular Biology (ASBMB), April 02-06, 2016 San Diego, USA; Federation of American Societies for Experimental Biology (FASEB), June 12-17, 2016 Florida, USA

Track: 10 Glycobiology & Structural biology

Glycobiology and Structural biology seeks to provide a complete and coherent picture of biological phenomena with glycans at the molecular and atomic level. The goals of structural biology include developing a comprehensive understanding of the molecular shapes and forms embraced by biological macromolecules and extending this knowledge to understand how different molecular architectures are used to perform the chemical reactions that are central to life. Most recent topics related to structural biology are: Structural Biochemistry, Structure and Function Determination, Glycolipids, Hybrid Approaches for Structure Prediction, Structural Biology in Cancer Research, Computational Approaches in Structural Biology, Structural Biology Databases.

Relevant Conferences: Glycobiology Conferences Biochemistry Conferences

7th International Conference on Bioinformatics, October 24-26, 2016 Rome, Italy; International Conference on Structural Biology, August 22-23, 2016 New Orleans, USA; International Conference on Glycomics, December 01-02, 2016 Atlanta, Georgia, USA; International Conference on Nucleic Acids, August 04-05, 2016 New Orleans, Louisiana, USA; 2nd International Conference on Transcriptomics, September 12-14, 2016 Philadelphia, Pennsylvania, USA; International Conference on Obesity & Chronic Diseases, July 25-27, 2016 Las Vegas USA; International Conference on New Therapeutics for Diabetes and Obesity, April 17-20, 2016 La Jolla, USA; Conference on Plasma Spectrochemistry, January 10-16, 2016 Tucson, USA; Euro Fed Lipid Congress, September 18-21, 2016 Gent, Belgium; Conference on Obesity and Adipose Tissue Biology, February 15-19, 2016 Banff, Canada; Society for Glycobiology, November 19-22, 2016 New Orleans, Louisiana, USA; American Society for Biochemistry and Molecular Biology (ASBMB), April 02-06, 2016 San Diego, USA; Federation of American Societies for Experimental Biology (FASEB), June 12-17, 2016 Florida, USA

Track: 11 Glycans in Genetic Disorders

Carbohydrates were prominent in the early history of immunology in defining the identity of antigens recognized by antibodies. In addition, the ability of antibodies to specifically recognize glycans was exploited in studies defining the size of the antigen-binding site. Nevertheless, for many decades following these early discoveries the broader potential importance of carbohydrates in both innate and adaptive immune responses was largely overlooked. However, times are changing and glycobiologists and immunologists are now collaborating extensively to explore this very fertile area of immunobiologyNumerous carbohydrate-binding proteins, or lectins, have been identified on the surfaces of immune cells. Interactions of lectins with glycans usually require several monosaccharide moieties presented in the correct conformation for high-affinity binding. Modification of proteins and lipids by glycosylation is a highly regulated process resulting in a diverse repertoire of glycan structures.

Glycans are at the center of many disorders and diseases sparking the possibility of exploiting them for therapeutic and diagnostic purposes. There are many biochemical pathways and diseases in which glycans are intricately involved. Gaging the vast potential and the promise that glycobiology holds, many pharma and biotech companies have already started allocating their R&D budget to it. Presently, with our drug arsenal fast depleting against drug resistant and mutant pathogens, glycobiology hold an untapped source of new candidate drugs.

Relevant Conferences: Glycobiology Conferences Biochemistry Conferences

7th International Conference on Bioinformatics, October 24-26, 2016 Rome, Italy; International Conference on Structural Biology, August 22-23, 2016 New Orleans, USA; International Conference on Glycomics, December 01-02, 2016 Atlanta, Georgia, USA; International Conference on Nucleic Acids, August 04-05, 2016 New Orleans, Louisiana, USA; 2nd International Conference on Transcriptomics, September 12-14, 2016 Philadelphia, Pennsylvania, USA; International Conference on Obesity & Chronic Diseases, July 25-27, 2016 Las Vegas USA; International Conference on New Therapeutics for Diabetes and Obesity, April 17-20, 2016 La Jolla, USA; Conference on Plasma Spectrochemistry, January 10-16, 2016 Tucson, USA; Euro Fed Lipid Congress, September 18-21, 2016 Gent, Belgium; Conference on Obesity and Adipose Tissue Biology, February 15-19, 2016 Banff, Canada; Society for Glycobiology, November 19-22, 2016 New Orleans, Louisiana, USA; American Society for Biochemistry and Molecular Biology (ASBMB), April 02-06, 2016 San Diego, USA; Federation of American Societies for Experimental Biology (FASEB), June 12-17, 2016 Florida, USA

Track: 12 Glycobiology in Personalized Medicine

The human gut hosts trillions of bacteria that directly influence human health. The majority of gut microbiota play an important role in nutrition by metabolizing host-indigestible complex glycans into short-chain fatty acids. Growth of the mesh-like peptidoglycan (PG) sacculus located between the bacterial inner and outer membranes (OM) is tightly regulated to ensure cellular integrity, maintain cell shape, and orchestrate division. Cytoskeletal elements direct placement and activity of PG synthases from inside the cell, but precise spatiotemporal control over this process is poorly understood. Glycan catabolism contains metabolic pathway maps for glycans. Some of them contain an alternative representation of glycan biosynthesis or degradation, called the glycan structure map.

Asparagine (N)-linked protein glycosylation is a ubiquitous co- and post-translational modification which can alter the biological function of proteins and consequently affects the development, growth, and physiology of organisms. In mammals, complex N-glycans are involved in different cellular processes including molecular recognition and signalling events.

Relevant Conferences: Glycobiology Conferences Biochemistry Conferences

7th International Conference on Bioinformatics, October 24-26, 2016 Rome, Italy; International Conference on Structural Biology, August 22-23, 2016 New Orleans, USA; International Conference on Glycomics, December 01-02, 2016 Atlanta, Georgia, USA; International Conference on Nucleic Acids, August 04-05, 2016 New Orleans, Louisiana, USA; 2nd International Conference on Transcriptomics, September 12-14, 2016 Philadelphia, Pennsylvania, USA; International Conference on Obesity & Chronic Diseases, July 25-27, 2016 Las Vegas USA; International Conference on New Therapeutics for Diabetes and Obesity, April 17-20, 2016 La Jolla, USA; Conference on Plasma Spectrochemistry, January 10-16, 2016 Tucson, USA; Euro Fed Lipid Congress, September 18-21, 2016 Gent, Belgium; Conference on Obesity and Adipose Tissue Biology, February 15-19, 2016 Banff, Canada; Society for Glycobiology, November 19-22, 2016 New Orleans, Louisiana, USA; American Society for Biochemistry and Molecular Biology (ASBMB), April 02-06, 2016 San Diego, USA; Federation of American Societies for Experimental Biology (FASEB), June 12-17, 2016 Florida, USA

Track: 13 Gycans in Vaccine Development

Glycans are at the center of many disorders and diseases sparking the possibility of exploiting them for therapeutic and diagnostic purposes. There are many biochemical pathways and diseases in which glycans are intricately involved. Gaging the vast potential and the promise that glycobiology holds, many pharma and biotech companies have already started allocating their R&D budget to it. Presently, with our drug arsenal fast depleting against drug resistant and mutant pathogens, glycobiology hold an untapped source of new candidate drugs.

The rapid increase in research and development expenditure by pharmaceutical and biotech companies, and increased funding in proteomics and glycobiology research will be the two most important growth drivers for this market in the forecast period (2012–2019).

Relevant Conferences: Glycobiology Conferences Biochemistry Conferences

7th International Conference on Bioinformatics, October 24-26, 2016 Rome, Italy; International Conference on Structural Biology, August 22-23, 2016 New Orleans, USA; International Conference on Glycomics, December 01-02, 2016 Atlanta, Georgia, USA; International Conference on Nucleic Acids, August 04-05, 2016 New Orleans, Louisiana, USA; 2nd International Conference on Transcriptomics, September 12-14, 2016 Philadelphia, Pennsylvania, USA; International Conference on Obesity & Chronic Diseases, July 25-27, 2016 Las Vegas USA; International Conference on New Therapeutics for Diabetes and Obesity, April 17-20, 2016 La Jolla, USA; Conference on Plasma Spectrochemistry, January 10-16, 2016 Tucson, USA; Euro Fed Lipid Congress, September 18-21, 2016 Gent, Belgium; Conference on Obesity and Adipose Tissue Biology, February 15-19, 2016 Banff, Canada; Society for Glycobiology, November 19-22, 2016 New Orleans, Louisiana, USA; American Society for Biochemistry and Molecular Biology (ASBMB), April 02-06, 2016 San Diego, USA; Federation of American Societies for Experimental Biology (FASEB), June 12-17, 2016 Florida, USA

 

 





Conference Details

Conference Series LLC feels great to invite you all to attend “3rd Glycobiology World Congress (Glycobiology-2017)” which is going to be held during June 26-28, 2017 at London, UK on a theme “Glycobiology: Simple construction of sweet glycoprobes”. Glycobiology-2017 welcomes biochemists, researchers, molecular biologists, industry experts, delegates, sponsors and exhibitors from all over the world to the extraordinary splendid city of London, UK.

Conference Series LLC Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.

Global glycobiology market was valued at $512.38 million in 2014 and poised to grow at a CAGR of 12.62% between 2012 and 2019, to reach $928.11 million in 2019. The rapid increase in research and development expenditure by pharmaceutical and biotech companies, and increased funding in proteomics and glycobiology research will be the two most important growth drivers for this market in the forecast period (2012–2019).

Join us in London and experience the World's Greatest Glycobiologists Scientist Meet.





Market Analysis Report

3rd Glycobiology World Congress

(Theme: Glycobiology: Simple construction of sweet glycoprobes)

About the Conference:

Glycobiology-2017 welcomes attendees, presenters, and exhibitors from all over the world to London, UK. We are delighted to invite you all to attend and register for the “3rd Glycobiology World Congress (Glycobiology-2017)” which is going to be held during June 26-282017 in London, UK.

The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Glycobiology-2017, where you will be sure to have a meaningful experience with scholars from around the world. All the members of the Glycobiology-2017 organizing committee look forward to meeting you in London, UK.

For more details please visit- http://glycobiology.conferenceseries.com/index.php

Importance & Scope:

      Most aspects of Glycobiology depend on successful researches. Glycobiology is a process to a new innovation, a new era. Glycobiology-2017 aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results about all aspects of Glycobiology leading way to the unraveled. It also provides the chance for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the fields of Glycobiology.

Glycobiology-2017 is a quint essential platform for presenting research about marketing, exchanging ideas about it and thus, contributes to the dissemination of knowledge for the benefit of both the academia and business. Glycobiology is where the future intersects. This event brings together eminent researchers and associates to explore the emerging field. We bring together Knowledge, creative, and technology leaders from the Biology industry for the most current and relevant discussions.

Why London?

     London is the capital city of England and the United Kingdom. It is the most populous city in the United Kingdom with a metropolitan area of over 13 million inhabitants. Standing on the River Thames, London has been a major settlement for two millennia. London has a diverse range of peoples and cultures, and more than 300 languages are spoken within Greater London. London is a leading global city, with strengths in the arts, commerce, education, entertainment, fashion, finance, healthcare, media, professional services, research and development, tourism and transport all contributing to its prominence., London became a Centre for the worldwide youth culture, exemplified by the Swinging London subculture associated with the Kings Road, Chelsea and Carna by Street. London is the seat of the Government of the United Kingdom. The city is split by the River Thames into North and South, with an informal central London area in its interior. London has a temperate oceanic climate, similar to much of southern Britain. The Monument in the City of London provides views of the surrounding area while commemorating the Great Fire of London, which originated nearby. With increasing industrialization, London population grew rapidly throughout the 19th and early 20th centuries, and it was for some time in the late 19th and early 20th centuries the most populous city in the world until overtaken by New York City in 1925. London is the most populous city and metropolitan area of the European Union and the second most populous in Europe.

   Glycobiology Market Global Forecast to 2019: The Glycobiology market will reach $928.11 million by 2019, growing at a CAGR of 12.62% during the forecast period (2014–2019). This report segment the global Glycobiology market by application, end users, products, and geographies. According to the World Bank, funding for research and development activities in Asia was about $158.94 billion in 2001 and increased to $329.31 billion in 2010. Similarly, in the U.S., overall funding for research and development was about $291.77 billion in 2001, which increased to $428.94 billion in 2010. Increased funding activities are expected to positively impact the growth of the Glycobiology enzymes, instruments, kits, and reagents market. A combination of bottom-up and top-down approaches were used to calculate market sizes and growth rates of the global Glycobiology enzymes. Secondary information was used to identify overall revenue, geographic reach, and product portfolios of market players. [Source: Ref3]

Conference Highlights:

·         Glycobiology

·         Glyco-Biomarkers

·         Glyco Immunology

·         Glycoprotein Technologies

·         Glyco-Bioinformatics

·         Glycans in Drug Design

·         Glycobiology & Biotechnology

·         Glycans in Diseases and Therapeutics

·         Glycobiology in Personalized Medicine

·         Glycans in development and genetic disorders

·        Glycobiology of Biopharmaceuticals and Vaccines

Why to attend???

MEET YOUR TARGET MARKET with members from around the world focused on learning about Biological research and growing market, this is your single best opportunity to reach the largest assemblage of participants from the scientific community. Conduct demonstrations, distribute information, meet with current and potential customers, and make a splash with a new product line, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, tactics, and the newest updates in Glycobiology growing market are hallmarks of this conference.

Be Part of it!

• This conference focusing on all the major aspects in the fields of Glycobiology.

• It would be beneficial for all the students who ever willing to enter into research to the respective fields.

• As bringing the major research to the market and making it to utility are major focus for all the companies, this conference would be opportunity for the people in the respective fields.

 A Unique Opportunity for Advertisers and Sponsors at this International event:                                            

http://www.omicsgroup.com/conferences/ACS/conference/pdfs/glycobiology2017_Sponsorship.pdf

Major Glycobiology Associations around the Globe

    Glyconet Glycobiotechnology Network

    Glycoscience Graduate School

    Mizutani Foundation for Glycoscience

    The Japanese Society of Carbohydrate Research

    Alberta Glycomics Centre

    Copenhagen Center for Glycomics

    CKSP: Center of Know-how for Sugars and Polysaccharides, Ben-Gurion University

    Laboratory of Carbohydrate Chemistry, Institute of Bioorganic Chemistry, Russian Academy of Science

    Glycoprotein Structure/Function Group, Birkbeck College

    Oxford Glycobiology Institute

    Centre for Glycobiology, University of Liverpool

    IBS: Institut de Biologie Structurale

    Glycoscience Team, National Centre for Biomedical Engineering Science, National University of Ireland, Galway

Major Glycobiology Related Associations in London

Glycosciences Laboratory

Oxford Glycobiology Institute

Glycobiology Group

Glycotechnology Core Resource

Glycobiology Research and Training Center

Glycomics Center

Heparin Home Page, Rensselaer Polytechnic Institute

Resource for Integrated Glycotechnology

Institute of Molecular Biomembrane and Glycobiology

Target Audience:

Directors/Managers & Business Delegates,  Director of Laboratories, Universities, Industries, Investigators, Post-Doctoral Fellows, Research and Diagnostic Laboratories, Clinical Fellows, Students and Biomedical Research companies.  

Academia      60%

Industry        30%

Others           10%

Glance at Market of Glycobiology:

The technological progress in biochemistry and molecular biology has played a significant role in the development of the glycobiology market during the last decade. Also, the improvements in analytical instruments, and data processing and analysis software have contributed significantly in the advancement of the glycobiology field. The presence of research funding and government support for conducting research and commercialization of the products in the glycobiology market is the primary driver for the growth of this market. Glycobiology science is used extensively in biomarker discovery and drug assessment. Thus, the rapid growth experienced by pharmaceutical and biotechnology industries is assisting the growth of the glycobiology market.

The global glycomics market was valued at $512.38 million in 2014 and poised to grow at a CAGR of 12.62% between 2012 and 2019, to reach $928.11 million in 2019. The rapid increase in research and development expenditure by pharmaceutical and biotech companies, and increased funding in proteomics and glycobiology research will be the two most important growth drivers for this market in the forecast period (2012–2019). Geographic analysis reveals that North America accounted for the largest share of the global glycomics market in 2014, due to increasing funding for proteomics and glycomics research. For instance, in August 2013, the National Institutes of Health (NIH) provided $5.5 million to the National Center for Functional Glycomics (NCFG) for research into the identification of glycans and complex carbohydrates using glycan microarrays. Similarly, in 2011, the University Of Nevada School Of Medicine received $10 million for glycobiology research from NIH. [Source: Ref2]

The major players in this market include Agilent Technologies (U.S.), Bruker Corp. (U.S.), Danaher Corp. (U.S.), New England Biolabs (U.S.), Prozyme Inc. (U.S.), Shimadzu Corp. (Japan), Sigma-Aldrich Corp. (U.S.), Takara Bio (Japan), Thermo Fisher Scientific (U.S.), and Waters Corp. (U.S). [Source: Ref1]

References:

1.      http://www.whatech.com/market-research-reports/press-release/medical/32147-worldwide-glycobiology-market-grow-at-a-cagr-of-12-62-to-reach-928-11-million-by-2019

2.      http://www.marketsandmarkets.com/PressReleases/glycobiology.asp

3.      http://www.marketsandmarkets.com/Market-Reports/glycobiology-market-132685525.html

4.     http://www.glyco.ac.ru/worldglycoscience.html

5.      http://www.glycoforum.gr.jp/square/newsE.html

 





Past Conference Report

Glycobiology 2016

The 2nd Glycobiology World Congress was held in Atlanta, USA, during August 29-31, 2016.

Glycobiology 2016 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the field of Glycobiology and biochemistry. The highly exalted conference hosted by Conference Series LLC was marked with the attendance of renowned and brilliant researchers, business delegates and talented student communities representing more than 20 countries around the world. The conference has tried grounding every aspect related to Glycobiology and Biochemistry, covering all the possible research areas and crux.  

The conference aimed a parallel rail with theme “Glycobiology: The bitter side of the sweet world”. The meeting engrossed a vicinity of cognizant discussions on novel subjects like Biochemistry, Molecular Biology, Deep Sequencing, Computational Approaches in Biochemistry, Hybrid Approaches for Ligand Prediction, Signalling Biology, Bioinformatics Databases, Molecular Modelling and Simulation, Drug Designing, Frontiers in Glycobiology and Recent Advances in Glycobiology. The three days event implanted a firm relation of upcoming strategies in the field of Glycobiology with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

We are thankful to all our speakers for encouraging and supporting us to conduct the conference and catapulting the same to pinnacle of success.

The Organizing Committee would like to thank the moderator Dr. Iva Turyan, Biogen, USA for her contributions which resulted in smooth functioning of the conference.

A series of invited lectures by Honorable guests and members of the Keynote Forum marked the commencement of the event. Prominent speakers like Julian M Menter from Morehouse School of Medicine, USA; Myron R Szewczuk from Queen’s University, Canada; Rachel Chen from Georgia Institute of Technology, USA; Carole Creuzenet from The University of Western Ontario, Canada; Sven Bahrke, Glycotope GmbH, Germany and Cheorl-Ho Kim from Sungkyunkwan University, Korea gave their fruitful contributions in the form of highly informative presentations and made the conference a top notch one.

Conference Series LLC is prerogative to thank the Organizing Committee Members, Keynote speakers, Chair and Co-chairs on transcribing the plenary sessions and workshops in a diversified and variegate manner to make this conference an enviable artefact.

Conference Series LLC offers its heartfelt appreciation to our Exhibitors “S-BIO, USA” and “EY Laboratories, Inc., USA”. We also express our sincere thanks to all the media partners for the promotion of our event to glory.

The best poster presentations were awarded by Prof. Myron R Szewczuk from Queen’s University, Canada to:

Maria O Longas, Purdue University, USA

Conference Series LLC, on behalf of the conference, congratulates the Best poster awardees for their outstanding performance in the field of Glycobiology and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavours.

Conference Series LLC 3rd Glycobiology World Congress would not have reached the pinnacle if not with the support of International, multi-professional steering committee and coordination of the Journal of Glycobiology: Open Access, Journal of Glycomics and Lipidomics and Journal of Diabetes and Metabolism; hence, we express our deep sense of gratitude.

After the successful completion of Glycobiology 2016 we are glad to announce our next upcoming conference which is going to be held in London, UK

“3rd Glycobiology World Congress” which is going to be held during June 26-28, 2017 in London, UK” with the theme “Glycobiology: Simple construction of sweet glycoprobes”.

Mark your calendars; we are hoping to see you soon!

Let us meet again @ Glycobiology 2017


Past Reports  Gallery  



Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date June 26-28, 2017
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity
Poster Opportunity Available

Media Partners

Conferenceseries Destinations